The complex of recombinant human insulin-like growth factor-I (rhIGF-I) and its binding protein-5 (IGFBP-5) induces local bone formation in murine calvariae and in rat cortical bone after local or systemic administration
- PMID: 11437468
- DOI: 10.1054/ghir.2000.0181
The complex of recombinant human insulin-like growth factor-I (rhIGF-I) and its binding protein-5 (IGFBP-5) induces local bone formation in murine calvariae and in rat cortical bone after local or systemic administration
Abstract
The influence of recombinant human insulin-like growth factor-I (rhIGF-I), its binding protein-5 (IGFBP-5) or their equimolar complexes on calvarial osteogenesis was investigated by quantitative radiography and histomorphometry after local administration to adult mice or mature rats. The systemic effects of these proteins were investigated in aged Sprague-Dawley rats with regard to their ability to prevent or restore bone mass in ovariectomy induced osteopenia as assessed by radiography, dual-energy X-ray absorptiometry (DEXA) analyses, peripheral computerized tomography (pQCT) and mineral analyses after daily s.c. administration for 3 or 8 weeks following a bone depletion period of 8 weeks. Bone mass of murine calvariae was significantly increased in a dose-dependent manner by the complex 7 days after discontinuation of local administration for 19 days in mice, whereas IGF-I alone expressed only weak effects. IGFBP-5 alone was ineffective in this respect. In the same model, only the complex had a weak osteogenetic potential in 7 week or 5 month old rats. Systemic long-term treatment with the complex of rhIGF-I/IGFBP-5 (2.0/7.6 mg/kg/day, s.c.) for 8 weeks resulted in significantly increased cortical thickness, area and mineral density in femoral midshaft or tibial metaphysis suggesting periosteal bone formation. This was obviously related to increased muscle strength since these effects were parallelled by increased body weight. No effect on trabecular bone occurred as demonstrated by site-specific analyses (vertebrae, proximal tibia) using DEXA, pQCT and radiography. This selective action of rhIGF-I/IGFBP-5 on periosteal bone formation is unique for an IGFBP. Femoral ash and calcium content, both corrected for tissue volume, increased slightly. However, when the increase in cortical thickness and bone mass was corrected for bone size, the effects are nearly abolished, suggesting an additional effect of bone growth. This potential deserves further evaluation in order to differentiate between effects on cortical bone via muscle strength and lack of efficacy on trabecular bone balance.
Copyright 2001 Harcourt Publishers Ltd.
Similar articles
-
The effects of recombinant human insulin-like growth factor (rhIGF)-1 and rhIGF-1/IGF binding protein-3 administration on rat osteopenia induced by ovariectomy with concomitant bilateral sciatic neurectomy.J Bone Miner Res. 1995 Dec;10(12):1853-64. doi: 10.1002/jbmr.5650101204. J Bone Miner Res. 1995. PMID: 8619365
-
Effects of recombinant human growth hormone and insulin-like growth factor-I, with or without 17 beta-estradiol, on bone and mineral homeostasis of aged ovariectomized rats.J Bone Miner Res. 1996 Nov;11(11):1723-35. doi: 10.1002/jbmr.5650111116. J Bone Miner Res. 1996. PMID: 8915780
-
Benefit of systemically administered rhIGF-I and rhIGF-I/IGFBP-3 on cancellous bone in ovariectomized rats.J Bone Miner Res. 1994 Aug;9(8):1301-12. doi: 10.1002/jbmr.5650090820. J Bone Miner Res. 1994. PMID: 7526611
-
Effects of magnesium on skeletal metabolism.Magnes Trace Elem. 1990;9(1):1-14. Magnes Trace Elem. 1990. PMID: 2184830 Review.
-
Potential role of rhIGF-I/IGFBP-3 in maintaining skeletal mass in space.Bone. 1998 May;22(5 Suppl):145S-147S. doi: 10.1016/s8756-3282(98)00006-4. Bone. 1998. PMID: 9600772 Review.
Cited by
-
The Role of GH/IGF Axis in Dento-Alveolar Complex from Development to Aging and Therapeutics: A Narrative Review.Cells. 2021 May 12;10(5):1181. doi: 10.3390/cells10051181. Cells. 2021. PMID: 34066078 Free PMC article. Review.
-
Pregnancy-associated plasma protein-A increases osteoblast proliferation in vitro and bone formation in vivo.Endocrinology. 2006 Dec;147(12):5653-61. doi: 10.1210/en.2006-1055. Epub 2006 Aug 31. Endocrinology. 2006. PMID: 16946002 Free PMC article.
-
Function of matrix IGF-1 in coupling bone resorption and formation.J Mol Med (Berl). 2014 Feb;92(2):107-15. doi: 10.1007/s00109-013-1084-3. Epub 2013 Sep 26. J Mol Med (Berl). 2014. PMID: 24068256 Free PMC article. Review.
-
Ras-association domain family 1 protein, RASSF1C, is an IGFBP-5 binding partner and a potential regulator of osteoblast cell proliferation.J Bone Miner Res. 2005 Aug;20(8):1430-9. doi: 10.1359/JBMR.050311. Epub 2005 Mar 14. J Bone Miner Res. 2005. PMID: 16007340 Free PMC article.
-
Identification and characterization of novel IGFBP5 interacting protein: evidence IGFBP5-IP is a potential regulator of osteoblast cell proliferation.Am J Physiol Cell Physiol. 2006 Mar;290(3):C900-6. doi: 10.1152/ajpcell.00563.2004. Epub 2005 Nov 2. Am J Physiol Cell Physiol. 2006. PMID: 16269403 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous